149 related articles for article (PubMed ID: 12135970)
1. Excessive recruitment of neural systems subserving logical reasoning in schizophrenia.
Ramsey NF; Koning HA; Welles P; Cahn W; van der Linden JA; Kahn RS
Brain; 2002 Aug; 125(Pt 8):1793-807. PubMed ID: 12135970
[TBL] [Abstract][Full Text] [Related]
2. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.
Snitz BE; MacDonald A; Cohen JD; Cho RY; Becker T; Carter CS
Am J Psychiatry; 2005 Dec; 162(12):2322-9. PubMed ID: 16330597
[TBL] [Abstract][Full Text] [Related]
3. Effects of olanzapine on cerebellar functional connectivity in schizophrenia measured by fMRI during a simple motor task.
Stephan KE; Magnotta VA; White T; Arndt S; Flaum M; O'Leary DS; Andreasen NC
Psychol Med; 2001 Aug; 31(6):1065-78. PubMed ID: 11513374
[TBL] [Abstract][Full Text] [Related]
4. Schizophrenia and Parkinson's disease lead to equal motor-related changes in cortical and subcortical brain activation: an fMRI fingertapping study.
Müller JL; Deuticke C; Putzhammer A; Röder CH; Hajak G; Winkler J
Psychiatry Clin Neurosci; 2003 Dec; 57(6):562-8. PubMed ID: 14629703
[TBL] [Abstract][Full Text] [Related]
5. LORETA functional imaging in antipsychotic-naive and olanzapine-, clozapine- and risperidone-treated patients with schizophrenia.
Tislerova B; Brunovsky M; Horacek J; Novak T; Kopecek M; Mohr P; Krajca V
Neuropsychobiology; 2008; 58(1):1-10. PubMed ID: 18781085
[TBL] [Abstract][Full Text] [Related]
6. Do atypical antipsychotics fail to exert cognitive sparing effects?
Papageorgiou C; Oulis P; Vasios C; Matsopoulos GK; Uzunoglu N; Rabavilas A; Christodoulou GN
Neuroreport; 2003 Mar; 14(3):505-9. PubMed ID: 12634513
[TBL] [Abstract][Full Text] [Related]
7. Cognitive function in schizophrenic patients.
Tollefson GD
J Clin Psychiatry; 1996; 57 Suppl 11():31-9. PubMed ID: 8941169
[TBL] [Abstract][Full Text] [Related]
8. Risperidone versus other atypical antipsychotic medication for schizophrenia.
Gilbody SM; Bagnall AM; Duggan L; Tuunainen A
Cochrane Database Syst Rev; 2000; (3):CD002306. PubMed ID: 10908551
[TBL] [Abstract][Full Text] [Related]
9. Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by "resting state" functional magnetic resonance imaging.
Lui S; Li T; Deng W; Jiang L; Wu Q; Tang H; Yue Q; Huang X; Chan RC; Collier DA; Meda SA; Pearlson G; Mechelli A; Sweeney JA; Gong Q
Arch Gen Psychiatry; 2010 Aug; 67(8):783-92. PubMed ID: 20679586
[TBL] [Abstract][Full Text] [Related]
10. Effective connectivity during episodic memory retrieval in schizophrenia participants before and after antipsychotic medication.
Hutcheson NL; Sreenivasan KR; Deshpande G; Reid MA; Hadley J; White DM; Ver Hoef L; Lahti AC
Hum Brain Mapp; 2015 Apr; 36(4):1442-57. PubMed ID: 25504918
[TBL] [Abstract][Full Text] [Related]
11. [Atypical neuroleptics in the treatment of aggression and hostility in schizophrenic patients].
Briken P; Nika E; Krausz M; Naber D
Fortschr Neurol Psychiatr; 2002 Mar; 70(3):139-44. PubMed ID: 11880946
[TBL] [Abstract][Full Text] [Related]
12. Clozapine to olanzapine.
Millson RC; Delva NJ
Am J Psychiatry; 1999 Jul; 156(7):1121. PubMed ID: 10401476
[No Abstract] [Full Text] [Related]
13. Working memory capacity in schizophrenia: a parametric fMRI study.
Jansma JM; Ramsey NF; van der Wee NJ; Kahn RS
Schizophr Res; 2004 Jun; 68(2-3):159-71. PubMed ID: 15099600
[TBL] [Abstract][Full Text] [Related]
14. Changes in prefrontal and amygdala activity during olanzapine treatment in schizophrenia.
Blasi G; Popolizio T; Taurisano P; Caforio G; Romano R; Di Giorgio A; Sambataro F; Rubino V; Latorre V; Lo Bianco L; Fazio L; Nardini M; Weinberger DR; Bertolino A
Psychiatry Res; 2009 Jul; 173(1):31-8. PubMed ID: 19428222
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
Bilder RM; Goldman RS; Volavka J; Czobor P; Hoptman M; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Kunz M; Chakos M; Cooper TB; Horowitz TL; Lieberman JA
Am J Psychiatry; 2002 Jun; 159(6):1018-28. PubMed ID: 12042192
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia.
Bitter I; Dossenbach MR; Brook S; Feldman PD; Metcalfe S; Gagiano CA; Füredi J; Bartko G; Janka Z; Banki CM; Kovacs G; Breier A;
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):173-80. PubMed ID: 14687871
[TBL] [Abstract][Full Text] [Related]
17. Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia.
Sharma T; Hughes C; Soni W; Kumari V
Psychopharmacology (Berl); 2003 Sep; 169(3-4):398-403. PubMed ID: 12845415
[TBL] [Abstract][Full Text] [Related]
18. "Normalization" of brain activation in schizophrenia. An fMRI study.
Lund A; Kroken R; Thomsen T; Hugdahl K; Smievoll AI; Barndon R; Iversen J; Landrø NI; Sundet K; Rund BR; Ersland L; Lundervold A; Asbjørnsen A
Schizophr Res; 2002 Dec; 58(2-3):333-5. PubMed ID: 12409175
[No Abstract] [Full Text] [Related]
19. Aberrant network connectivity during error processing in patients with schizophrenia.
Voegler R; Becker MP; Nitsch A; Miltner WH; Straube T
J Psychiatry Neurosci; 2016 Mar; 41(2):E3-12. PubMed ID: 26836622
[TBL] [Abstract][Full Text] [Related]
20. Auditory mismatch impairments are characterized by core neural dysfunctions in schizophrenia.
Gaebler AJ; Mathiak K; Koten JW; König AA; Koush Y; Weyer D; Depner C; Matentzoglu S; Edgar JC; Willmes K; Zvyagintsev M
Brain; 2015 May; 138(Pt 5):1410-23. PubMed ID: 25743635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
